StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$3.01−0.37 (-10.81%)

Close on Nov 17, 2026Market cap $58.22MP/E –Yield –

Corbus Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Corbus Pharmaceuticals's price to sales ratio was 135.6× on Jul 29, 2022, against 60.7× a year earlier. Over the last 5 years it ranged from 8.5× to 169.0×, with a median of 75.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 2022135.6×+85.5
2021Dec 31, 202150.1×+32.5
2020Dec 31, 202017.6×+7.6
2019Dec 31, 20199.9×−105.5
2018Dec 31, 2018115.5×−11.2
2017Dec 29, 2017126.7×−69.0
2016Dec 30, 2016195.6×–

More Corbus Pharmaceuticals figures

See a number that looks wrong?